STL Volume 11 Number 4
3 POSTS 0 COMMENTS
Skin conditions and treatments introduced in 2005 including Clindamycin Foam 1% Aluma®Skin Renewal System with FACES™, Meropenem for Injection MERREM® AstraZeneca, Moxifloxacin HCl Avelox® Bayer HealthCare Schering-Plough, Tygacycline Tygacil®, and other drugs and conditions.
Although the developing fetus was once considered protected from the outside world, we now know that it can potentially be affected by any medication given to the mother. Therapeutic options available for these patients will be discussed.